|
|
|
October 25, 2017: 1 - 2:40pm ET
Commercial Reasonableness in Physician Compensation Arrangements |
This webinar will discuss the threshold of Commercial Reasonableness as it applies to compensation for physician services, a trend which has seen significant growth in recent years. Commercial Reasonableness, a threshold that is related to, but distinct from, Fair Market Value, has emerged as a focus of regulatory scrutiny for healthcare transactions. The discussion will focus on the qualitative and quantitative analysis undertaken to meet the applicable regulatory pronouncements required for establishing Commercial Reasonableness, as well as the interplay between Fair Market Value and Commercial Reasonableness in healthcare transactions. Presenter, Robert James Cimasi, MHA, ASA, FRICS, MCBA, CVA, CM&AA, serves as Chief Executive Officer of Health Capital Consultants, a nationally recognized healthcare financial and economic consulting firm headquartered in St. Louis, MO, serving clients in 49 states since 1993. Mr. Cimasi has over 35 years of experience in serving clients, with a professional focus on the financial and economic aspects of healthcare service sector entities including: valuation consulting and capital formation services; healthcare industry transactions including joint ventures, mergers, acquisitions, and divestitures; litigation support & expert testimony; and, certificate-of-need and other regulatory and policy planning consulting. |
|
Who Should Attend
|
Learning Objectives
|
|
|
Valuation professionals CPAs in the healthcare industry Attorneys Hospital and health system c-suite executives (e.g. CEOs, CFOs, COOs) Healthcare consultants |
Define the thresholds of Commercial Reasonableness, as derived from statutory and regulatory pronouncements, as well as relevant case law and other sources. Articulate the interplay (from the appraiser's standpoint) between Fair Market Value and Commercial Reasonableness in the context of transactions including physician compensation elements. Identify the qualitative analysis undertaken to determine whether the anticipated transaction is legally permissible under the threshold of Commercial Reasonableness. Identify the quantitative analysis undertaken to determine whether the anticipated transaction is legally permissible under the threshold of Commercial Reasonableness. Differentiate between the qualitative and quantitative analyses. |
Instructional Delivery Method: Group Live Internet-Based. The instructional method is lecture with active group participation and visual aids. CPE Credit: 2 Field of Study: Specialized Knowledge and Application Prerequisite: None Program Level: Intermediate Advanced Preparation: None Cancel at any time for a full refund. |
|
|
Cost and Registration
(Click your membership level to register.) |
|
All complaints or grievances should be directed to Joel Shiffrin, President, at 888-406-0088 or via email.
|
 |
CPA Leadership Institute, Inc. is registered with the National Association of the State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of the individual courses for CPE credit. Complaints regarding registered sponsors may be addressed to the National Registry of CPE Sponsors, 150 Fourth Avenue North, Suite 700, Nashville, TN, 37219-2417. Web site: www.nasba.org. |